Covered recipient · General Payments record
MOHAMMED ASGAR
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2023
$480.65
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $263.64 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NuVasive, Inc. | $85.57 | 1 |
| Merck Sharp & Dohme Corporation | $46.76 | 3 |
| ORGANOGENESIS INC. | $27.73 | 1 |
| SK Life Science, Inc. | $24.66 | 1 |
| Otsuka America Pharmaceutical, Inc. | $24.03 | 1 |
| ABBVIE INC. | $21.92 | 1 |
| Amgen Inc. | $16.61 | 1 |
| MEDLINE INDUSTRIES LP | $16.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $21.92 | 02/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996168933 | CMS |
| Amgen Inc. | $16.61 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020644473 | CMS |
| MEDLINE INDUSTRIES LP | $16.36 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1017473717 | CMS |
| Merck Sharp & Dohme LLC | $19.30 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048505807 | CMS |
| Merck Sharp & Dohme LLC | $13.24 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048804083 | CMS |
| Merck Sharp & Dohme LLC | $14.22 | 04/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048505809 | CMS |
| NuVasive, Inc. | $85.57 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049525843 | CMS |
| Organogenesis Inc. | $27.73 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048104329 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.03 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014196945 | CMS |
| SK Life Science, Inc. | $24.66 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054762049 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.